Table 1

Characteristics of pregnant women with COVID-19

All patients (n=1043)Severe cases (n=56)Non-severe cases (n=987)P value
n%n%n%
Maternal age*
 Median (IQR) (years)3026–343329–383026–34<0.0001
 Under 20151.400.0151.51.00
 20–2947145.21425.045746.40.002
 30–3950148.13460.746747.40.05
 Over 40545.2814.3464.70.002
Characteristic
 Nulliparous†48046.62239.345847.10.26
 Multiple pregnancy‡171.735.7141.50.06
Pregnancy period at diagnosis
 Median (IQR) (weeks)2616–333226–352515–33<0.0001
 First trimester20219.411.820120.4<0.0001
 Second trimester38036.41526.836537.00.12
 Third trimester46144.24071.442142.7<0.0001
Epidemiological history
 Familial infection53751.52850.050951.60.82
 Community acquired16415.71017.915415.60.65
 Nosocomial infection181.711.8171.71.00
 Workplace infection504.811.8495.00.51
 Unknown27426.31628.625826.10.69
Comorbidities§
 Diabetes80.823.660.60.07
 Chronic hypertension70.723.650.50.05
 Asthma363.547.1323.30.13
 Body mass index>25373.658.9323.30.045
Pregnancy complications
 Hypertensive disorders of pregnancy191.923.8171.80.27
 HELLP syndrome30.300.030.31.00
 Gestational diabetes mellitus404.059.4353.70.06
 Placental abruption30.311.920.20.15
 Deep venous thrombosis10.100.010.11.00
Course of pregnancy
 Pregnancy ongoing19218.458.918718.90.07
 Delivery52650.44173.248549.10.001
 Delivery during infection16415.72850.013613.8<0.0001
 Spontaneous abortion121.200.0121.21.00
 Induced abortion40.400.040.41.00
 Stillbirth10.100.010.11.00
 Unknown30829.51017.929830.20.05
  • Data are presented as n (%) or median (IQR). The p value is a comparison of severe and non-severe cases.

  • *Excluding 2 cases with missing data

  • †Excluding 14 cases with missing data

  • ‡Excluding 47 cases with missing data

  • §Excluding 10 cases with missing data

  • HELLP, Hemolysis, elevated liver enzymes, and low platelet count.